Skip to main content

Renninger Robert's Form 4 filing

LeonaBio, Inc. (LONA) · filed Jan 5, 2026

Accession no.
0002037968-26-000002
Filed
Jan 5, 2026
Trade date
Nov 18, 2025-Jan 2, 2026
Filing delay
48 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.04K. It was filed 48 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Renninger RobertCIK 0002037968Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 18, 2025Common StockAGrant or awardAcquired+1,000$2.31+$2,31011,918Direct
Dec 31, 2025Common StockMOption exerciseAcquired+1,236$0.00$013,154Direct
Jan 2, 2026Common StockSSaleDisposed−297$6.88−$2,043.3612,857Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 31, 2025Common StockMOption exerciseDisposed−1,236$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)